Takara Bio Inc

Takara Bio Inc

Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,774.00
  • Today's Change-12.00 / -0.67%
  • Shares traded175.70k
  • 1 Year change-32.08%
  • Beta0.6499
Data delayed at least 20 minutes, as of Dec 02 2022 06:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • 4974:TYO price falls below 50-day moving average to 1,759.00 at 09:28 GMT
  • 4974:TYO price moved over -1.09% to 1,812.00
  • 4974:TYO trading volume exceeds daily average by +17.63%

Key statistics

On Friday, Takara Bio Inc (4974:TYO) closed at 1,774.00, 7.00% above its 52-week low of 1,658.00, set on Oct 21, 2022.
52-week range
1,658.00Oct 21 20222,730.00Dec 16 2021
Markit short selling activity
Previous close1,786.00
Average volume204.23k
Shares outstanding120.42m
Free float47.07m
P/E (TTM)11.62
Market cap213.62bn JPY
EPS (TTM)152.62
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateMar 30 2022
Div pay-dateJun 27 2022
Next div ex-dateMar 30 2023
Next div pay-date--
Data delayed at least 20 minutes, as of Dec 02 2022 06:00 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.